Hans Lilja
41 – 50 of 469
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume
Vertosick, Emily A. LU ; Zappala, Stephen ; Punnen, Sanoj ; Hugosson, Jonas ; Boorjian, Stephen A. ; Haese, Alexander ; Carroll, Peter ; Cooperberg, Matthew ; Bjartell, Anders LU and Lilja, Hans LU
, et al.
(2021)
In Urology
157.
p.102-106
- Contribution to journal › Article
-
Mark
Two-Step Acoustophoresis Separation of Live Tumor Cells from Whole Blood
Undvall Anand, Eva LU ; Magnusson, Cecilia LU ; Lenshof, Andreas LU
; Ceder, Yvonne
LU
; Lilja, Hans
LU
and Laurell, Thomas
LU
(2021)
In Analytical Chemistry
93(51).
p.17076-17085
- Contribution to journal › Article
-
Mark
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): : initial results from an international prospective study
Bancroft, Elizabeth K ; Johannsson, Oskar LU ; Lilja, Hans LU
; Axcrona, Karol
LU
and Eeles, Rosalind A
(2021)
In The Lancet Oncology
22(11).
p.1618-1631
- Contribution to journal › Article
- 2020
-
Mark
Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels
Li, Weiqiang ; Bicak, Mesude ; Sjoberg, Daniel D. ; Vertosick, Emily ; Dahlin, Anders LU ; Melander, Olle LU
; Ulmert, David
LU
; Lilja, Hans
LU
and Klein, Robert J.
(2020)
In Prostate
80(16).
p.1405-1412
- Contribution to journal › Article
-
Mark
Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years : A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
Kovac, Evan ; Carlsson, Sigrid V. LU ; Lilja, Hans LU
; Hugosson, Jonas
; Kattan, Michael W.
; Holmberg, Erik
and Stephenson, Andrew J.
(2020)
In JAMA Network Open
3(1).
- Contribution to journal › Article
-
Mark
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
(2020) In Proceedings of the National Academy of Sciences of the United States of America 117(26). p.15172-15181
- Contribution to journal › Article
-
Mark
Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB
Bicak, Mesude ; Wang, Xing ; Gao, Xiaoni ; Xu, Xing ; Väänänen, Riina Minna ; Taimen, Pekka ; Lilja, Hans LU
; Pettersson, Kim
and Klein, Robert J.
(2020)
In Human Molecular Genetics
29(10).
p.1581-1591
- Contribution to journal › Article
-
Mark
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
- Contribution to journal › Article
-
Mark
The Four-Kallikrein Panel Is Effective in Identifying Aggressive Prostate Cancer in a Multiethnic Population
(2020) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29(7). p.1381-1388
- Contribution to journal › Article
-
Mark
Reply by Authors
Stuopelyte, Kristina ; Sabaliauskaite, Rasa ; Bakavicius, Arnas ; Haflidadóttir, Benedikta S. LU ; Visakorpi, Tapio ; Väänänen, Riina Minna ; Patel, Chintan ; Danila, Daniel C. ; Lilja, Hans LU
and Lazutka, Juozas R.
, et al.
(2020)
In The Journal of urology
204(1).
p.77-78
- Contribution to journal › Article